The opioid crisis has affected many families and communities throughout our region and state — and we recognize the importance of life-saving initiatives to support those with substance use disorders.
Compass Health recently signed a Collaborative Drug Therapy Agreement with our partners at Genoa Healthcare. Starting July 29, 2019, the Genoa Healthcare pharmacy locations at our Bailey Center in Everett and the McLeod Clinic in Bellingham will provide a naloxone kit (Narcan) to anyone with Medicaid or other insurance without the need for a provider visit or a prescription.
“This will help save lives and decrease emergency department visits and hospital stays in the communities that we serve,” said Compass Health’s Chief Medical Officer, Camis Milam, M.D.
Narcan is the first FDA-approved nasal spray that can stop or reverse the effects of an opioid overdose. Because Narcan nasal spray does not require assembly and can be administered without medical training, it is a safe, effective way to help those in need.
We’re proud to make Narcan more accessible to our communities, and only require individuals to have active insurance. There will be no forms or records kept regarding referrals and the pharmacy will comply with all federal and state regulations regarding dispensing.
Our ongoing partnership with Genoa underscores our commitment to integrated care that supports whole person health. Together, we can serve vital roles in our community safety net, helping to save lives and promote hope and recovery.